|
 |
 |
ART Advanced Research Technologies, Inc.
(ARA.TO: TSX)
11.01.09
Coverage Termination
|
|
|
|
ART Advanced Research Technologies, Inc.
(ARA.TO: TSX)
08.17.09
Cash Position Strengthened with Debt Financing, Government Grant and Quarterly Revenues of $1M
|
|
|
|
ART Advanced Research Technologies, Inc.
(ARA.TO: TSX)
05.18.09
Sales Execution is a Must in FY09 as Q1/09 Lowered Expectation
|
|
|
|
ART Advanced Research Technologies, Inc.
(ARA.TO: TSX)
04.02.09
The Image is the Gold Standard but a Show Me Attitude Still Persists
|
|
|
 |
|
Advaxis, Inc.
(ADXS.OB; NASDAQ)
12.31.08
Coverage Termination
|
|
 |
|
Neurobiological Technologies, Inc.
(NTII: NASDAQ)
12.18.08
Coverage Termination
|
|
|
|
ART Advanced Research Technologies, Inc.
(ARA.TO: TSX)
11.17.08
Growing the Installed Base in this Economy, Traction Continues with Significant Improvement
|
|
 |
|
Generex Biotechnology Corp.
(GNBT; NASDAQ)
11.10.08
Breaking-out the Sum of the Parts: Antigen Express’ Novel Cancer Immunotherapy Emerges as a Jewel
|
|
|
|
Neurobiological Technologies, Inc.
(NTII: NASDAQ)
09.18.08
Defining Outcome Scenarios, Probabilities Appear Focused to the Upside and Future Appreciation
|
|
 |
|
VioQuest Pharmaceuticals, Inc.
(VOQP.OB; NASDAQ)
08.25.08
Creating Value; Turnaround Leverages Product Opportunities while Expectation Abounds and Losses Decrease
|
|
|
|
ART Advanced Research Technologies, Inc.
(ARA.TO: TSX)
08.18.08
The Way Forward; Investment Validates Lack of OptixTM Sales and Share Price in a Changing World
|
|
 |
|
Arbios Systems, Inc.
(NASDAQ: OTC.BB)
08.05.08
Coverage Termination
|
|
|
|
Generex Biotechnology Corp.
(GNBT; NASDAQ)
07.30.08
RapidMistTM the Non-Invasive Oral Drug Delivery Platform, Sets the Tone as Best in Class Followed by an Expanding Pipeline and Global Revenues.
|
|
|
|
VioQuest Pharmaceuticals, Inc.
(VOQP.OB; NASDAQ)
07.29.08
510k Application Submitted for XyfidTM and Priority Review Voucher for LenoctaTM Focuses Milestones and Share Price Appreciation.
|
|
|
|
Advaxis, Inc.
(ADXS.OB; NASDAQ)
07.15.08
The New Generation of Cancer Immunotherapeutics.
|
|
|
|
VioQuest Pharmaceuticals, Inc.
(VOQP.OB; NASDAQ)
06.16.08
Robust Pipeline of Niche’ Cancer Therapies with Billion Dollar Upside.
|
|
|
|
ART Advanced Research Technologies, Inc.
(ARA.TO: TSX)
05.20.08
Getting Past a Year of Transformation.
|
|
|
|
Neurobiological Technologies, Inc.
(NTII: NASDAQ)
05.15.08
It’s all about Viprinex; Interim Results are Due in First Half of FY09 for Realization of Greater Shareholder Value.
|
|
|
|
ART Advanced Research Technologies, Inc.
(ARA.TO: TSX)
03.30.08
Shaking the Tree; Sales Growth Continues Accentuating Gross Margins While Efficiencies Reform the Burn Rate.
|
|
|
|
Neurobiological Technologies, Inc.
(NTII: NASDAQ)
02.13.08
When You Review Stroke Treatments, Look at One Stroke Drug at a Time; Each One Is Different.
|
|
|
 |
|
Nventa Biopharmaceuticals, Corp.
(NVN.TO, TSX)
12.17.07
A Very Promising Therapeutic and Vaccine Candidate for the Treatment of Diseases Caused by the Human Papillomavirus (HPV).
|
|
|
|
Arbios Systems, Inc.
(NASDAQ: OTC.BB)
12.03.07
A New Tool for Rescuing Patients Who’s Livers Are Failing.
|
|
|
|
ART Advanced Research Technologies, Inc.
(ARA.TO: TSX)
11.19.07
Reversing the Trend by Energizing Optix®’s Commercialization Strategy with a Higher Margin Opportunity and Sales Leadership.
|
|
|
|
Neurobiological Technologies, Inc.
(NTII: NASDAQ)
11.13.07
Injecting Confidence to the Viprinex™ Mission by a Successful $60m Offering; Mountains Do Move.
|
|
 |
|
StatSure Diagnostic Systems, Inc.
(NASDAQ:SSUR; OTC:BB)
11.06.07
FDA Approves CLIA Waiver for StatSure’s Patented Barrel Technology for Rapid HIV Testing.
|
|
|
|
StatSure Diagnostic Systems, Inc.
(NASDAQ:SSUR; OTC:BB)
10.25.07
Opportunity Unfolds for Investors Seeking to Participate In Proprietary Point-of-Care Product Firm.
|
|
|
|
Arbios Systems, Inc.
(NASDAQ: OTC.BB)
09.13.07
Enhancing the Survival of Patients with Life Threatening Episodes of Liver Failure.
|
|
|
|
ART Advanced Research Technologies, Inc.
(ARA.TO: TSX)
08.20.07
Mapping the Road Ahead With an Execution Agenda.
|
|
|
|
ART Advanced Research Technologies, Inc.
(ARA.TO: TSX)
05.16.07
The Future and the Products are Now in Their Hands.
|
|
 |
|
Advanced Cell Technology, Inc.
(OTC: BB: ACTC)
05.08.07
"Hemangioblast" Precursor Cells Produced From Human Embryonic Stem Cells Show Remarkable Ability to Repair Vascular Damage in Animals.
|
|
|
|
Arbios Systems, Inc.
(NASDAQ: OTC.BB)
04.26.07
SEPET™ Advances Facilitate a Financing with New Institutional Investors.
|
|
|
|
Advanced Cell Technology, Inc.
(OTC: BB: ACTC)
04.18.07
Translating Stem Cell Development into Therapeutic Outcomes.
|
|
|
|
ART Advanced Research Technologies, Inc.
(ARA.TO: TSX)
03.27.07
A CE Marking for the EU and an Unconditional Health Canada Medical Device License to Commercialize SoftScan®, a Financing and an Extension of its Agreement with GE Healthcare for eXplore Optix™
|
|
|
|
Neurobiological Technologies, Inc.
(NTII: NASDAQ)
02.13.07
Royalties Pour In, Momentum Rebuilds, Losses Decrease and Encouraging Viprinex™ Clinical Trials Advance Supported by the Role of Fibrinogen in Influencing Stroke Outcome.
|
|
|
|
Advanced Cell Technology, Inc.
(OTC: BB: ACTC)
01.29.07
The Road to Commercial Development of New Therapies from Stem Cells.
|
|
|
|
Arbios Systems, Inc.
(NASDAQ: OTC.BB)
01.17.07
Developing Multiple Products to Meet the Unmet Medical Needs of Patients in Liver Crisis.
|
|
|
|
|
ART Advanced Research Technologies, Inc.
(ARA.TO: TSX)
12.05.06
Filling the Coffers while Remapping the Future.
|
|
|
|
StatSure Diagnostic Systems, Inc.
(NASDAQ:SSUR; OTC:BB)
11.20.06
Rapid Point of Care Diagnostics for Near Term Cash Flow.
|
|
|
|
ART Advanced Research Technologies, Inc.
(ARA.TO: TSX)
11.16.06
Recapitalizing and Reorganizing with an Emphasis on Execution.
|
|
|
|
Neurobiological Technologies, Inc.
(NTII: NASDAQ)
11.14.06
A Rich Royalty Stream, Record Revenues, a Decreased Loss and a Completed Restatement.
|
|
|
|
ART Advanced Research Technologies, Inc.
(ARA.TO: TSX)
08.07.06
SoftScan® Advances Medical Device License Application in Canada.
|
|
|
|
ART Advanced Research Technologies, Inc.
(ARA.TO: TSX)
05.18.06
Strategic Investors Buying Again.
|
|
|
|
Neurobiological Technologies, Inc.
(NTII: NASDAQ)
05.11.06
First and Ten: Moving Ahead on Ancrod Stroke Clinical Trials.
|
|
|
|
ART Advanced Research Technologies, Inc.
(ARA.TO: TSX)
03.13.06
Acquisition Further Integrates to the Preclinical and Clinical Markets.
|
|
|
|
Neurobiological Technologies, Inc.
(NTII: NASDAQ)
02.13.06
Potential of Stroke Drug Would Fill a Huge Unmet Need.
|
|
|
|
|
Neurobiological Technologies, Inc.
(NTII: NASDAQ)
11.11.05
Advancing the Treatment Window.
|
|
|
|
ART Advanced Research Technologies, Inc.
(ARA.TO: TSX)
11.04.05
Directions to the Future.
|
|
|
|
Neurobiological Technologies, Inc.
(NTII: NASDAQ)
09.20.05
"Neurobiological Sells Brain Tumor Compound, XERECEPT® Rights for $33 Million"
|
|
|
|
Neurobiological Technologies, Inc.
(NTII: NASDAQ)
08.25.05
"Remember the Story of the Tortoise and the Hare."
|
|
|
|
ART Advanced Research Technologies, Inc.
(ARA.TO: TSX)
08.08.05
"Making R&D More Effective through Smarter Technologies."
|
|
|
|
Neurobiological Technologies, Inc.
(NTII: NASDAQ)
05.11.05
"Allocating to the Clinical Initiative."
|
|
|
|
ART Advanced Research Technologies, Inc.
(ARA.TO: TSX)
03.23.05
"Achieving a Critical Mass".
|
|
|
|
Neurobiological Technologies, Inc.
(NTII: NASDAQ)
02.10.05
"A Convergence of Advancements."
|
|
